John C. Akitt, President of Trial Management Group Inc., is pleased to announce the acceptance of the FOCUS Cognitive Flu Study abstract as a poster presentation at the International Union of Microbiological Societies Congress in Montreal, July 27 – August 1, 2014. The FOCUS study, “Effect of Oseltamivir Treatment on Cognitive and Mood Decrements Associated with Influenza: A Randomised, Controlled Study”, is the first study sponsored by TMG.